The publication aims to describe the characteristics of a population-based cohort with multiple sclerosis and their exposure to disease-modifying drugs in four Canadian provinces.
Citation
Huah Shin Ng, Feng Zhu, Elaine Kingwell, Yinshan Zhao, Shenzhen Yao, Okechukwu Ekuma, Lawrence W Svenson, Charity Evans, John D. Fisk, Ruth Ann Marrie & Helen Tremlett (2021) Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting, Expert Review of Neurotherapeutics, 21:1, 131-140, DOI: 10.1080/14737175.2021.1847085.